telomere targeting

Advertisement

cGxPJobs Banner

MAIA Activates U.S. Site for Phase 2 Lung Cancer Trial

CHICAGO, April 16, 2026 MAIA Biotechnology, Inc. has announced the activation of its first U.S. clinical site for the...

By cGxPwire Editor
April 17, 2026

Read More

Advertisement

cGxPJobs

Directory